Record MS-N189 · Supportive care · Last literature search and appraisal: 31 October 2026
Evidence at a glance
- Evidence label: Promising but preliminary comparative evidence
- Potential benefit: A 98-person randomized trial found greater short-term improvement in pain and shoulder movement with therapist-delivered myofascial release than with manual lymphatic drainage.
- Risk: Usually low when adapted, but pressure should avoid healing wounds, infected or inflamed skin, suspected thrombosis, fragile bone and known tumor sites.
- What this evidence is about: Supportive rehabilitation after breast surgery and radiotherapy; it does not test recurrence, tumor response or survival.
What was studied
Adults with shoulder pain or stiffness after breast-cancer surgery and adjuvant radiotherapy were randomized to myofascial release or manual lymphatic drainage. A trained physiotherapist delivered four sessions; outcomes were measured after session four and one month later. Pain medians changed from 7 to 3 with myofascial release and 6 to 4 with drainage; the report also favored myofascial release for range of motion and disability. The active-comparator design helps answer which hands-on approach worked better in this setting, but there was no no-treatment arm and masking participants or therapists was not feasible.
What the evidence cannot establish
Single-center study, short follow-up, specialized delivery and incomplete reporting of clinically meaningful thresholds limit certainty. Full text was reviewed. Funding was not verified in the reviewed report; the authors reported no conflict of interest.
Symptom improvement is not evidence of tumor shrinkage, delayed recurrence or longer survival. This record does not support replacing oncology treatment.
Practical safety context
This is not the same as vigorous deep-tissue massage. Ask whether the therapist has oncology-rehabilitation training and how treatment will be modified for radiated skin, lymphedema risk, recent surgery, low platelets, anticoagulation, bone metastases or a central line.
Questions for the care team
- Is my pain due to scar/fascial restriction, joint injury, nerve injury or cancer—does it need evaluation first?
- Is myofascial release appropriate given my surgery, radiation field and lymphedema risk?
- What functional measure and stopping rule will we use?
Sources checked
Source note: Publication dates refer to the indexed paper; links were checked on 31 October 2026. A registry entry verifies design or status, not efficacy. Unreported fields are not assumed to be absent.
Education only: This evidence summary is not personal medical advice. Decisions about symptoms, treatment interactions and complementary care belong with your oncology team.
